Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryota Shiraki

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Organic Letters|January 31, 2025
Synthesis of Polyamides Bearing Directing Groups and Their Catalytic DepolymerizationRyota Shiraki, Yu-I Hsu, Hiroshi Uyama, et al.
The Journal of Organic Chemistry|April 19, 1996
Total Synthesis of Natural PI-091, a New Platelet Aggregation Inhibitor of Microbial OriginRyota Shiraki, Akihiko Sumino, Kin-ichi Tadano Ki, et al.
Journal of the American Chemical Society|January 10, 2022
Nickel-Catalyzed Addition of C-C Bonds of Amides to Strained Alkenes: The 1,2-Carboaminocarbonylation ReactionYuri Ito, Syun Nakatani, Ryota Shiraki, et al.
Clinical and Experimental Nephrology|June 22, 2017
Development and validation of a Fall Risk Assessment Index for dialysis patientsKenichi Kono, Yusuke Nishida, Hiroki Yabe, et al.
The Journal of Organic Chemistry|October 24, 2001
Total Synthesis of (-)-Verrucarol(1)Jun Ishihara, Rie Nonaka, Yuki Terasawa, et al.
Bioorganic & Medicinal Chemistry|August 30, 2008
Synthesis and pharmacological evaluation of bis-3-(3,4-dichlorophenyl)acrylamide derivatives as glycogen phosphorylase inhibitorsKenichi Onda, Ryota Shiraki, Yasuhiro Yonetoku, et al.
Chemical & Pharmaceutical Bulletin|August 2, 2019
Discovery and Biological Evaluation of Potent and Orally Active Human 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors for the Treatment of Type 2 Diabetes MellitusTakanori Koike, Ryota Shiraki, Daisuke Sasuga, et al.
Bioorganic & Medicinal Chemistry|April 25, 2008
Synthesis of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives as inhibitors of human liver glycogen phosphorylase aKenichi Onda, Takayuki Suzuki, Ryota Shiraki, et al.
Bioorganic & Medicinal Chemistry|October 28, 2008
Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitorsKenichi Onda, Ryota Shiraki, Takashi Ogiyama, et al.
Bioorganic & Medicinal Chemistry|April 18, 2012
Discovery of Ipragliflozin (ASP1941): a novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitusMasakazu Imamura, Keita Nakanishi, Takayuki Suzuki, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Organic Letters|January 31, 2025
Synthesis of Polyamides Bearing Directing Groups and Their Catalytic DepolymerizationRyota Shiraki, Yu-I Hsu, Hiroshi Uyama, et al.
The Journal of Organic Chemistry|April 19, 1996
Total Synthesis of Natural PI-091, a New Platelet Aggregation Inhibitor of Microbial OriginRyota Shiraki, Akihiko Sumino, Kin-ichi Tadano Ki, et al.
Journal of the American Chemical Society|January 10, 2022
Nickel-Catalyzed Addition of C-C Bonds of Amides to Strained Alkenes: The 1,2-Carboaminocarbonylation ReactionYuri Ito, Syun Nakatani, Ryota Shiraki, et al.
Clinical and Experimental Nephrology|June 22, 2017
Development and validation of a Fall Risk Assessment Index for dialysis patientsKenichi Kono, Yusuke Nishida, Hiroki Yabe, et al.
The Journal of Organic Chemistry|October 24, 2001
Total Synthesis of (-)-Verrucarol(1)Jun Ishihara, Rie Nonaka, Yuki Terasawa, et al.
Bioorganic & Medicinal Chemistry|August 30, 2008
Synthesis and pharmacological evaluation of bis-3-(3,4-dichlorophenyl)acrylamide derivatives as glycogen phosphorylase inhibitorsKenichi Onda, Ryota Shiraki, Yasuhiro Yonetoku, et al.
Chemical & Pharmaceutical Bulletin|August 2, 2019
Discovery and Biological Evaluation of Potent and Orally Active Human 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors for the Treatment of Type 2 Diabetes MellitusTakanori Koike, Ryota Shiraki, Daisuke Sasuga, et al.
Bioorganic & Medicinal Chemistry|April 25, 2008
Synthesis of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives as inhibitors of human liver glycogen phosphorylase aKenichi Onda, Takayuki Suzuki, Ryota Shiraki, et al.
Bioorganic & Medicinal Chemistry|October 28, 2008
Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitorsKenichi Onda, Ryota Shiraki, Takashi Ogiyama, et al.
Bioorganic & Medicinal Chemistry|April 18, 2012
Discovery of Ipragliflozin (ASP1941): a novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitusMasakazu Imamura, Keita Nakanishi, Takayuki Suzuki, et al.
Pageof 1